您的位置: 专家智库 > >

国家自然科学基金(30471678)

作品数:15 被引量:76H指数:6
相关作者:路平刘彩刚陈峻青王舒宝徐惠绵更多>>
相关机构:中国医科大学附属第一医院中国医科大学辽宁省肿瘤医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 15篇中文期刊文章

领域

  • 15篇医药卫生

主题

  • 7篇肿瘤
  • 7篇胃癌
  • 5篇病理
  • 4篇预后
  • 4篇早期胃癌
  • 4篇胃肿瘤
  • 4篇临床病理
  • 4篇淋巴
  • 4篇淋巴结
  • 3篇鼠骨
  • 3篇髓细胞
  • 3篇细胞
  • 3篇小鼠
  • 3篇小鼠骨髓
  • 3篇小鼠骨髓细胞
  • 3篇淋巴结转移
  • 3篇基因
  • 3篇骨髓
  • 3篇骨髓细胞
  • 2篇子宫

机构

  • 10篇中国医科大学...
  • 3篇中国医科大学
  • 2篇辽宁省肿瘤医...
  • 1篇台州市第一人...
  • 1篇沈阳市妇婴医...
  • 1篇北京京煤集团...
  • 1篇癌症研究所

作者

  • 10篇路平
  • 5篇刘彩刚
  • 5篇陈峻青
  • 5篇王舒宝
  • 4篇徐惠绵
  • 3篇鲁阳
  • 2篇司荣祥
  • 2篇金锋
  • 2篇陈波
  • 2篇王永来
  • 2篇张瑞山
  • 2篇刘金龙
  • 2篇庞葵
  • 2篇李华
  • 2篇关华鹤
  • 1篇李立峰
  • 1篇赵祥
  • 1篇何爱萍
  • 1篇姚凡
  • 1篇王俊科

传媒

  • 2篇山东医药
  • 2篇Chines...
  • 2篇中华肿瘤防治...
  • 1篇中华胃肠外科...
  • 1篇中国老年学杂...
  • 1篇中华外科杂志
  • 1篇中国普通外科...
  • 1篇中国肿瘤临床
  • 1篇中国临床康复
  • 1篇Chines...
  • 1篇中国临床保健...
  • 1篇中国医药

年份

  • 1篇2010
  • 2篇2009
  • 1篇2008
  • 8篇2007
  • 1篇2006
  • 2篇2005
15 条 记 录,以下是 1-10
排序方式:
逆转录病毒载体介导的双耐药基因转染小鼠骨髓细胞的实验研究被引量:1
2006年
目的:将耐药基因以逆转录病毒为载体转染骨髓细胞以解决大剂量化疗所造成的骨髓抑制。方法:以逆转录病毒为载体,将双突变的二氢叶酸还原酶基因(DH-FR)和胞苷脱氨基酶基因(CD)转染小鼠骨髓细胞,观察该细胞耐MTX及Ara-C的CFU-GM生成情况;RT-PCR检测转基因的表达情况。结果:转基因的小鼠骨髓细胞有耐药克隆形成(14%);基因转染后小鼠骨髓细胞对MTX和Ara-C的耐受明显增加,P<0·005;RT-PCR显示转基因细胞有转染的基因条带。结论:双耐药基因通过逆转录病毒转染小鼠骨髓细胞并且获得表达,提高了骨髓细胞对MTX和Aar-C的耐药性。
高海德路平陈波金锋姚凡王舒宝刘金龙赵实诚
关键词:基因疗法骨髓细胞
胃中部癌前哨淋巴结邻近、横向和跳跃性转移的临床分析被引量:2
2007年
目的探讨胃中部癌前哨淋巴结的分布规律,为合理淋巴结清除提供依据。方法从我院收治的1 825例胃癌患者中选取52例单个转移淋巴结的胃中部癌病例,分析转移淋巴结的位置分布及其与病理分级的关系。结果52例患者中N137例;N1以上15例。小弯侧癌35例,No.3(+)17例,No.4(+)5例,No.7(+)8例;大弯侧癌17例,No.4(+)7例,No.10(+)3例。病理分级在N1组和N1以上组间无统计学差异(P>0.05)。结论胃中部小弯侧癌术中,No.7应被切除,大弯侧癌手术时应注意探查No.10,如怀疑有转移应行脾切除。
刘彩刚王永来路平陈峻青
关键词:胃肿瘤淋巴转移前哨淋巴结
转染甲氨蝶呤阿糖胞苷双耐药基因的小鼠骨髓细胞对大剂量化学治疗的保护作用
2005年
目的探讨同时导入人双突变的二氢叶酸还原酶基因(DHFR)和胞苷脱氨基酶基因(CD)小鼠骨髓细胞对大剂量甲氨蝶呤(MTX)和阿糖胞苷(Ara-C)的耐受性及骨髓耐受联合化疗的可行性。方法以反转录病毒为载体,将人双突变的DHFR和CD通过共培养转染入两只小鼠骨髓干细胞,观察共培养后的骨髓细胞经Ara-C、MTX、Ara-C+MTX处理后,耐MTX及Ara-C粒-巨噬细胞集落形成单位(CFU-GM)生成情况;转基因小鼠骨髓细胞提取的DNA,用聚合酶链反应(PCR)检测转基因小鼠骨髓细胞耐药基因的表达。结果含有耐药基因(SFG-F/S-CD)的骨髓细胞均有耐药克隆的形成,耐Ara-C、MTX、Ara-C+MTX克隆分别为56%、22%和14%,并明显增加了对MTX和Ara-C的耐受(P<0.005);转基因小鼠骨髓细胞经PCR检测,显示有F/S、CD基因表达;耐药基因转染后小鼠骨髓细胞对MTX和Ara-C的耐受明显增加。结论双耐药基因可以导入小鼠骨髓细胞并且获得表达,提高了造血细胞对MTX和Aar-C的耐药性。
路平鲁阳庞葵王舒宝陈峻青徐惠绵王俊科赵实诚
关键词:小鼠骨髓细胞用药剂量化学治疗
Rational Operation for Primary Gastric Carcinoma with Liver Metastasis被引量:3
2007年
OBJECTIVE To investigate the prognosis of advanced gastric carcinoma patients with liver metastasis,and provide a foundation for rational opera- tions. METHODS The operations and prognosis of 102 primary gastric carci- noma patients with liver metastasis were studied retrospectively. RESULTS In gastric carcinoma patients with H1 metastasis who under- went a resection operation,the 6-month,1-and 2-year post-operative sur- vival rates were 61%,42%and 7%.There was a statistically significant dif- ference in survival between resected and non-resected patients(P=0.000) In gastric carcinoma cases with H2 metastasis,resection operations resulted in 54%,16%and 8%respective survival rates,with no significant difference compared to patients not receiving a resection(P=0.132).Gastric carcinoma patients with H3 metastasis who received a resection operation showed 25%,13%and 0%respective survivals with no significantly better prognosis compared to the non-resected cases(P=0.135).There was no statistical y significant difference in survival between the cases with or without peritoneal metastasis(P=0.152). CONCLUSION A resection operation provides a better prognosis for gas- tric carcinoma patients with H1 metastasis independent of peritoneal metas- tasis,but resection has no benefit for gastric carcinoma cases with H2 or H3 metastasis.Peritoneal metastases are not the significant influencing factor for the prognosis of gastric cancer with liver metastasis.
Caigang Liu Ping Lu Jinsong Gu Junqing Chen
关键词:原发性胃癌肝转移预后
子宫内膜癌化疗药物联合应用剂量的临床研究被引量:2
2010年
目的探讨紫杉醇(TXL)、阿霉素(ADM)和卡铂(CBDCA)(TAC方案)联合化疗治疗子宫内膜癌的最合适剂量。方法我院收治的子宫内膜癌患者34例均进行TAC联合化疗,起始剂量分别为ADM 35 mg/m2、TXL 120 mg/m2和CBDCA AUC 4,各药物的剂量逐渐增加。计划至少接受4个周期的治疗。如患有4级的嗜中性白血球减少症(DLT)或患有3级DLT伴发热者,允许在第2轮化疗后接受粒系集落刺激因子治疗。结果TAC方案的最大耐受剂量为:第1天ADM 45 mg/m2,第2天TXL 150 mg/m2和CBCDA AUC 5,且未出现严重的毒副作用。34例患者的总有效率50.0%,完全缓解率20.6%,中位生存时间29.0个月。结论对于子宫内膜癌的TAC疗法推荐剂量为第1天ADM 45 mg/m2、第2天TXL 150 mg/m2和CBCDA AUC 5,该方案具有理想的疗效及可接受的毒副作用。
高嵩何爱萍敖礼王永来
关键词:子宫内膜样抗肿瘤联合化疗方案
伴肝转移的Ⅳ期胃癌手术方式的合理选择被引量:8
2007年
目的探讨不同手术方式对伴肝转移的Ⅳ期胃癌患者的临床疗效。方法回顾性分析1993~2004年间102例伴肝转移的Ⅳ期胃癌病例的手术方式,评价不同术式对预后的影响。结果肝转移H1的胃癌病例行姑息切除后半年、1年和2年的生存率分别为69%、44%和6%,与改道手术、开腹探查术者的生存率比较,差异有统计学意义(P=0.009)。肝转移H2的胃癌病例姑息切除术后半年、1年和2年的生存率分别为56%、13%和6%,与改道手术、开腹探查术者的生存率比较,差异无统计学意义(P=0.068)。肝转移H1的胃癌病例行姑息切除半年、1年和2年的生存率分别为25%、13%和0,与改道手术、开腹探查术者的生存率比较,差异无统计学意义(P=0.157)。有或无腹膜转移的病例,其术后生存率比较,差异亦无统计学意义(P=0.132)。结论肝转移H1的胃癌患者,无论伴与不伴腹膜转移,均应尽量行姑息性切除手术。肝转移H2、H3的Ⅳ期胃癌患者行切除性手术无益于预后。
刘彩刚路平鲁阳王舒宝陈峻青
关键词:胃肿瘤肝转移预后
Relationship between Preoperative Clinicopathologic Characteristics and Lymph Node Metastasis in Early Gastric Cancer被引量:4
2007年
Objective: To investigate the features of the preoperative clinicopathologic characteristics in correlation with lymph node metastasis. Methods: The preoperative clinicopathologic characteristics and lymph node metastasis of 265 patients with early gastric carcinoma were analyzed retrospectively. Results: The three clinicopathologic characteristics, maximum cancer diameter >2cm under endoscope, poor differentiation and excavated type were significant high risk independent preoperative clinicopathologic characteristics(P<0.05). The patients who had none of the three preoperative clinicopathologic characteristics had no lymph node metastasis, while 27.27% of the patients who had all the three preoperative clinicopathologic characteristics had N2 lymph node metastasis. Conclusion: The three preoperative clinicopathologic characteristics, maximum cancer diameter under endoscope, cell differentiation and gross type were very useful to evaluate the extent of lymph node metastasis.
刘彩刚路平鲁阳张瑞山金锋徐惠绵王舒宝陈峻青
关键词:早期胃癌临床病理特性淋巴结转移
Clinicopathological Characteristics as Predictive Factrs for Lymph Node Metastasis in Submucosal Gastric Cancer被引量:1
2007年
OBJECTIVE To identify clinicopathological characteristics as predictive factors for lymph node metastasis in submucosal gastric cancer, and in addi- tion to establish objective criteria as indications for endoscopic submucosal dissection (ESD). METHODS Data from 130 patients with submucosal gastric cancer were collected, and the relationship between their clinicopathological characteris- tics and the presence of lymph node metastasis was retrospectively analyzed by multivariate analysis. RESULTS In the multivariate logistic regression model, a tumor size of 2 cm or more and an undifferentiated histologic type were found to be inde- pendent risk clinicopathological characteristics for lymph node metastasis. Among 130 patients with submucosal carcinoma, no lymph node metastases were observed in 17 patients who showed neither of the two risk clinicopath- ological characteristics. Lymph node metastasis occurred in 61.1% (22/36) of the patients who had both risk clinicopathological characteristics. CONCLUSION A tumor size of 2 cm or more and an undifferentiated histologic type were significantly and independently related to lymph node metastasis in submucosal gastric cancer. It is rational for the paitients with neither of these two independent risk clinicopathological characteristics to undergo an ESD.
Caigang Liu Ping Lu Yang Lu Lua Li Ruishan Zhang Huimian Xu Shubao Wang Junqing Chen
关键词:胃癌淋巴结转移临床病理学
去氧孕烯炔雌醇和米非司酮治疗功能失调性子宫出血的疗效观察被引量:16
2009年
目的观察诊断性刮宫术后加用去氧孕烯炔雌醇和米非司酮治疗围绝经期功能失调性子宫出血的临床效果。方法将103例确诊为围绝经期功能性子宫出血并伴有不同程度内膜增厚患者随机分为两组,分别服用去氧孕烯炔雌醇和米非司酮3个月进行治疗。治疗前后均检测血、尿常规,肝功能及血糖、血脂,卵泡刺激素、黄体生成素、雌二醇(E2)、孕酮(P)、泌乳素(PRL)和雄激素(T)。结果两组患者治疗1疗程后,贫血均有不同程度的改善,治疗后血E2、P平均水平均较用药前下降明显,差异具有统计学意义(P<0.05),而FSH、LH、PRL、T用药前后变化不明显。结论去氧孕烯炔雌醇及米非司酮对于围绝经期功能性子宫出血均有良好的临床疗效,不良反应小、经济、复发率低,是两种比较理想的药物治疗方案。
李立峰
关键词:功能性子宫出血刮宫术炔雌醇米非司酮
早期胃癌浆膜分型与淋巴结转移的关系被引量:6
2007年
目的:探讨早期胃癌浆膜分型与淋巴结转移的关系,为淋巴结的合理清除提供依据。方法:回顾性分析164例早期胃癌的浆膜分型与淋巴结转移情况。结果:浆膜正常型胃癌患者的淋巴结转移率为9.4%,反应型为20.2%,两者淋巴结转移率比较差异有统计学意义,χ2=3.85,P<0.05。浆膜正常型患者中,黏膜癌淋巴结转移率为2.0%,且局限于第1站(N1);黏膜下癌淋巴结转移率为20.0%,且局限于(N1+No.7)。浆膜反应型患者中,m癌、sm癌第2站(N2)转移率分别为3.0%和26.1%。结论:浆膜分型评估早期胃癌淋巴结的转移规律是较实用和可靠的方法。
刘彩刚路平肖建存张瑞山王舒宝陈峻青
关键词:胃肿瘤淋巴转移
共2页<12>
聚类工具0